Skip to content
10-Q

Quarterly Report

TRANSPHORM, INC.

0001715768-24-000009

← back to feed
Filed
Feb 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Feb 6, 2024 63.27M sh
Shares Diluted Q3 2024 · Dec 31, 2023 62.18M sh
Shares Diluted Q3 2024 · Dec 31, 2023 61.46M sh
Shares Diluted Q3 2024 · Dec 31, 2022 56.74M sh
Shares Diluted Q3 2024 · Dec 31, 2022 55.93M sh
Capex Q3 2024 · Dec 31, 2023 $623K
Capex Q3 2024 · Dec 31, 2022 $5.63M
Operating Cash Flow Q3 2024 · Dec 31, 2023 −$14.36M
Operating Cash Flow Q3 2024 · Dec 31, 2022 −$18.58M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $7.95M
Cash And Equivalents Q3 2024 · Mar 31, 2023 $15.53M
Cash And Equivalents Q3 2024 · Dec 31, 2022 $23.15M
Stockholders Equity Q3 2024 · Dec 31, 2023 $18.25M
Stockholders Equity Q3 2024 · Sep 30, 2023 $23.69M
Stockholders Equity Q3 2024 · Mar 31, 2023 $19.62M
Stockholders Equity Q3 2024 · Dec 31, 2022 $28.18M
Stockholders Equity Q3 2024 · Sep 30, 2022 $36.35M
Stockholders Equity Q3 2024 · Mar 31, 2022 $31.36M
Current Liabilities Q3 2024 · Dec 31, 2023 $12.41M
Current Liabilities Q3 2024 · Mar 31, 2023 $21.94M
Total Liabilities Q3 2024 · Dec 31, 2023 $14.41M
Total Liabilities Q3 2024 · Mar 31, 2023 $24.84M
Current Assets Q3 2024 · Dec 31, 2023 $20.95M
Current Assets Q3 2024 · Mar 31, 2023 $30.69M
Total Assets Q3 2024 · Dec 31, 2023 $32.66M
Total Assets Q3 2024 · Mar 31, 2023 $44.45M
Eps Diluted Q3 2024 · Dec 31, 2023 −$0.20
Eps Diluted Q3 2024 · Dec 31, 2023 −$0.54
Eps Diluted Q3 2024 · Dec 31, 2022 −$0.18
Eps Diluted Q3 2024 · Dec 31, 2022 −$0.38
Eps Basic Q3 2024 · Dec 31, 2023 −$0.20
Eps Basic Q3 2024 · Dec 31, 2023 −$0.54
Eps Basic Q3 2024 · Dec 31, 2022 −$0.18
Eps Basic Q3 2024 · Dec 31, 2022 −$0.38
Sga Expense Q3 2024 · Dec 31, 2023 $4.41M
Sga Expense Q3 2024 · Dec 31, 2023 $11.87M
Sga Expense Q3 2024 · Dec 31, 2022 $3.46M
Sga Expense Q3 2024 · Dec 31, 2022 $9.82M
Rd Expense Q3 2024 · Dec 31, 2023 $2.84M
Rd Expense Q3 2024 · Dec 31, 2023 $8.73M
Rd Expense Q3 2024 · Dec 31, 2022 $2.33M
Rd Expense Q3 2024 · Dec 31, 2022 $5.9M
Net Income Q3 2024 · Dec 31, 2023 −$10M
Net Income Q3 2024 · Dec 31, 2023 −$24.58M
Net Income Q3 2024 · Dec 31, 2022 −$10.46M
Net Income Q3 2024 · Dec 31, 2022 −$21.81M
Operating Income Q3 2024 · Dec 31, 2023 −$8.92M
Operating Income Q3 2024 · Dec 31, 2023 −$22.2M
Operating Income Q3 2024 · Dec 31, 2022 −$9.9M
Operating Income Q3 2024 · Dec 31, 2022 −$20.43M
Gross Profit Q3 2024 · Dec 31, 2023 $75K
Gross Profit Q3 2024 · Dec 31, 2023 $3.34M
Gross Profit Q3 2024 · Dec 31, 2022 −$2.67M
Gross Profit Q3 2024 · Dec 31, 2022 −$1.13M
Cost Of Revenue Q3 2024 · Dec 31, 2023 $4.6M
Cost Of Revenue Q3 2024 · Dec 31, 2023 $12.23M
Cost Of Revenue Q3 2024 · Dec 31, 2022 $7.16M
Cost Of Revenue Q3 2024 · Dec 31, 2022 $14.44M
Revenue Q3 2024 · Dec 31, 2023 $4.67M
Revenue Q3 2024 · Dec 31, 2023 $15.56M
Revenue Q3 2024 · Dec 31, 2022 $4.49M
Revenue Q3 2024 · Dec 31, 2022 $13.32M